Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥5,701,000 | ¥2,513,000 | ¥4,362,000 | ¥8,069,000 |
| Dep. & Amort. | ¥5,657,000 | ¥5,249,000 | ¥5,337,000 | ¥5,162,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥2,022,000 | -¥1,647,000 | ¥8,008,000 | -¥18,395,000 |
| Other Non-Cash | -¥1,136,000 | -¥223,000 | -¥1,000 | ¥2,205,000 |
| Operating Cash Flow | ¥8,200,000 | ¥5,892,000 | ¥17,706,000 | -¥2,959,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥8,970,000 | -¥4,380,000 | -¥7,601,000 | -¥10,341,000 |
| Net Acquisitions | ¥0 | ¥0 | ¥9,000 | ¥0 |
| Inv. Purchases | -¥1,240,000 | ¥0 | -¥203,000 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | -¥43,000 | -¥337,000 | ¥381,000 | -¥1,088,000 |
| Investing Cash Flow | -¥10,253,000 | -¥4,717,000 | -¥7,414,000 | -¥11,429,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥1,896,000 | ¥7,178,000 | ¥6,046,000 | ¥2,847,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥89,000 | -¥1,878,000 | -¥61,000 | -¥1,469,000 |
| Other Fin. Act. | -¥8,000 | ¥953,000 | ¥0 | ¥1,000 |
| Financing Cash Flow | -¥1,993,000 | ¥6,253,000 | ¥5,985,000 | ¥1,379,000 |
| Forex Effect | -¥579,000 | ¥49,000 | -¥68,000 | ¥1,013,000 |
| Net Chg. in Cash | -¥4,625,000 | ¥7,477,000 | ¥16,209,000 | ¥29,231,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥52,938,000 | ¥45,461,000 | ¥29,252,000 | ¥0 |
| End Cash | ¥48,313,000 | ¥52,938,000 | ¥45,471,000 | ¥29,231,000 |
| Free Cash Flow | -¥223,000 | ¥1,512,000 | ¥10,879,000 | -¥13,300,000 |